Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: J Affect Disord. 2016 Mar 2;197:43–50. doi: 10.1016/j.jad.2016.02.059

Table 1. Descriptive statistics for sample characteristics and study variables by genotype at baseline.

Val/Val (n=75) Val/Met or Met/Met (n=37)

Characteristic M ± SD or N (%) Range M ± SD or N (%) Range P
Age 51.4 ± 8.9 31 - 66 51.2 ± 7.0 34 - 64 .93a
BMI 25.1 ± 4.8 19 - 41 24.8 ± 4.6 18 - 41 .73a
Education .69b
 < College degree 13 (17.3) 8 (21.6)
 College degree 26 (34.7) 10 (27.0)
 > College degree 36 (48.0) 19 (51.4)
Caucasian ethnicity 63 (84.0) 31 (83.8) .48c
Sleep quality (PSQI) 7.17 ± 3.5 0 - 16 7.8 ± 3.6 1 - 16 .39a
Stage at diagnosis .20c
 0 8 (10.7) 9 (24.3)
 1 38 (50.1) 13 (35.1)
 2 25 (33.3) 12 (32.4)
 3 4 (5.3) 3 (8.1)
Surgery type .85b
 Lumpectomy 52 (69.3) 25 (67.6)
 Mastectomy 23 (30.7) 12 (32.4)
Cancer treatment .18c
 Neither radiation nor chemo 8 (10.7) 9 (24.3)
 Radiation only 29 (38.7) 11 (29.7)
 Chemo only 10 (13.3) 2 (5.4)
 Chemo & radiation 29 (37.3) 15 (40.5)
Time since treatment (mos.) 1.03 ± .94 .03 - 4 1.4 ± 1.2 .07 – 3.9 .09a
BDI-II total 8.93 ± 7.4 0 - 35 9.22 ± 7.5 0 - 32 .85a
 BDI-II cognitive 1.99 ± 2.8 0 - 17 2.05 ± 3.7 0 - 19 .92a
 BDI-II affective 1.48 ± 1.7 0 - 7 1.70 ± 1.8 0 - 7 .53a
 BDI-II somatic 5.46 ± 3.9 0 -15 5.46 ± 3.7 0 - 12 .99a
Inflammatory markers
 IL-6 (pg/mL) 1.62 ± .95 .47 – 5.6 1.57 ± 1.06 .44 – 6.16 .80a
 CRP (mg/L) 2.36 ± 3.1 .1 – 16.8 1.78 ± 2.1 .1 – 7.8 .30a
 sTNF-RII (pg/mL) 2305.9 ± 614.6 1305.7 - 3858 2298.2 ± 680.8 1354.3 – 3546 .95a
a

P-values for independent group t-tests comparing genotype group on continuous variables.

b

P-values from Chi-squared tests comparing genotype groups on categorical variables.

c

P-values from Fisher's exact tests comparing genotype groups on categorical variables with cell means <5.